Announced
Completed
Canaan Partners led a $16.5m series D round in Apnimed.
Synopsis
Canaan Partners, a venture capital firm, led a $16.5m series D round in Apnimed, a clinical-stage pharmaceutical company, with participation from Alpha Wave Ventures and other institutional investors.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite